发明名称 |
PHARMACEUTICAL COMPOSITION CONTAINING 2-PYRIMIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a]PYRIMIDIN-4-ONE AND 7-PYRIMIDINYL-2,3-DIHYDROIMIDAZO[1,2-a]PYRIMIDIN-5(1H)ONE DERIVATIVE |
摘要 |
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition containing a compound useful as an active component of a drug for preventing and/or treating neurodegenerative diseases such as Alzheimer disease. SOLUTION: The pharmaceutical composition contains a substance selected from a group consisting of pyrimidone derivatives represented by formula (I), their salts, their solvates and their hydrates as an active component. COPYRIGHT: (C)2010,JPO&INPIT
|
申请公布号 |
JP2010189422(A) |
申请公布日期 |
2010.09.02 |
申请号 |
JP20100097989 |
申请日期 |
2010.04.21 |
申请人 |
SANOFI-AVENTIS;MITSUBISHI TANABE PHARMA CORP |
发明人 |
GALLET THIERRY;LARDENOIS PATRICK;LOCHEAD ALISTAIR;MARGUERIE SEVERINE;NEDELEC ALAIN;SAADY MOURAD;SLOWINSKI FRANCK;YAICHE PHILIPPE |
分类号 |
A61K31/519;A61P3/04;A61P3/10;A61P9/00;A61P9/10;A61P11/00;A61P15/00;A61P17/02;A61P17/14;A61P19/08;A61P21/04;A61P25/00;A61P25/02;A61P25/08;A61P25/16;A61P25/18;A61P25/20;A61P25/24;A61P25/28;A61P25/34;A61P27/02;A61P27/06;A61P35/00;A61P35/02;A61P43/00;C07D487/04 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|